Novartis Czech Republic - Short-Term Debt

Created with Highcharts 6.0.4CZK mil2000200120022003200420052006200720082009201020112012201320142015201620170100200300400500

Novartis Czech Republic`s Short-Term Debt reached 51.2 CZK mil in 2017. This is 167 % more than in the previous year.

$1.99

Buy Short-Term Debt data for Novartis Czech Republic.

$19.99

Buy all data for Novartis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic CZK mil
Bayer Czech Republic CZK mil
GlaxoSmithKline Czech Republic CZK mil
Merck Czech Republic CZK mil
Novartis Czech Republic CZK mil
Pfizer Czech Republic CZK mil
Roche Czech Republic CZK mil
Sanofi-Aventis Czech Republic CZK mil
Servier Czech Republic CZK mil
Walmark CZK mil
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...             0 0 0 39.8 71.8    
... ... ...                 0 0 90.1 28.5 151    
... ... ...                 362 240 320 0 0    
... ...                   141 123 145 21.8 0    
                      205 55.2 0 96.0 0    
... ...                   856 0 0 0 0    
... ... ...                 0 151 285 541 660   ...
... ... ... ...               1,165 1,410 883 471 404    
... ... ... ... ... ... ... ... ... ... ... ... 0 0 0 0    
... ... ...                 195 31.0 62.4 194 1,413